Ikei S. Kobayashi

497 citations

24 papers · 337 indexed · h-index 9

Co-authors: Susumu Kobayashi Daniel B. Costa Fumiaki Nogaki Shigeki Miyawaki Tadashi Kamata Eri Muso Haruyoshi Yoshida Masanori Fujii
Topics: Renal Diseases and Glomerulopathies (6 papers)Lung Cancer Treatments and Mutations (6 papers)RNA modifications and cancer (4 papers)
Cited by: Nephrology Oncology Pulmonary and Respiratory Medicine
Journals: Blood The Journal of Immunology Cancer Research
Partner nations: Japan United States Singapore

In The Last Decade

Ikei S. Kobayashi

23 papers receiving 334 citations

Peers

Countries citing papers authored by Ikei S. Kobayashi

Since Specialization

Citations

This map shows the geographic impact of Ikei S. Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ikei S. Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ikei S. Kobayashi more than expected).

Fields of papers citing papers by Ikei S. Kobayashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ikei S. Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ikei S. Kobayashi. The network helps show where Ikei S. Kobayashi may publish in the future.

Co-authorship network of co-authors of Ikei S. Kobayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Ikei S. Kobayashi. A scholar is included among the top collaborators of Ikei S. Kobayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ikei S. Kobayashi. Ikei S. Kobayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integrative single-cell RNA-seq and spatial transcriptomics analyses reveal diverse apoptosis-related gene expression profiles in EGFR-mutated lung cancer 2024 ·Cell Death and Disease ·(unknown),Masanori Fujii,Ikei S. Kobayashi,Vivian Ho,Yukie Kashima,Hibiki Udagawa,Daniel B. Costa,Susumu Kobayashi	7
2	TIP60 is required for tumorigenesis in non‐small cell lung cancer 2023 ·Cancer Science ·(unknown),Naoki Akanuma,Ikei S. Kobayashi,Eunyoung Heo,Mariko Ando,Masanori Fujii,Feng Jiang,(unknown),(unknown),Kwok‐Kin Wong,Daniel B. Costa,Deepak Bararia,Daniel G. Tenen,Hideo Watanabe,Susumu Kobayashi	14
3	The Impact of On-Target Resistance Mediated by EGFR-T790M or EGFR-C797S on EGFR Exon 20 Insertion Mutation Active Tyrosine Kinase Inhibitors 2023 ·JTO Clinical and Research Reports ·Ikei S. Kobayashi,(unknown),Hollis Viray,Deepa Rangachari,Paul A. VanderLaan,Susumu Kobayashi,Daniel B. Costa	6
4	EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others with rare XPVAIK amino-acid insertions: Preclinical and clinical characterization of the favorable therapeutic window to all classes of approved EGFR kinase inhibitors 2023 ·Lung Cancer ·(unknown),Ikei S. Kobayashi,(unknown),Shriram K. Sundararaman,Meghan Lee,Deepa Rangachari,Paul A. VanderLaan,Susumu Kobayashi,Daniel B. Costa	3
5	An intrinsic purine metabolite AICAR blocks lung tumour growth by targeting oncoprotein mucin 1 2023 ·British Journal of Cancer ·(unknown),(unknown),(unknown),Ikei S. Kobayashi,Jiao Sun,Katerina Politi,Elena Levantini,Wei Zhang,Susumu Kobayashi,Wen Cai Zhang	8
6	Abstract 451: AICAR targets oncogenic signaling pathways of MUC1-CT 2023 ·Cancer Research ·(unknown),(unknown),Luís F.O. Silva,Ikei S. Kobayashi,Jiao Sun,Katerina Politi,Elena Levantini,Wei Zhang,Susumu Kobayashi,Wen Cai Zhang	1
7	Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer 2021 ·Cancer Research ·Yukie Kashima,(unknown),Ayako Suzuki,(unknown),Ikei S. Kobayashi,(unknown),Hibiki Udagawa,Hiroki Izumi,Yuji Shibata,Kosuke Tanaka,Masanori Fujii,Akihiro Ohashi,Masahide Seki,Kōichi Goto,Katsuya Tsuchihara,Yutaka Suzuki,Susumu Kobayashi	49
8	NAD Modulates DNA Methylation and Cell Differentiation 2021 ·Cells ·(unknown),(unknown),Giulia Gaggi,Lucrezia Rinaldi,Mahmoud A. Bassal,Yanzhou Zhang,Andy Joe Seelam,Ikei S. Kobayashi,(unknown),Alexander K. Ebralidze,Barbara Ghinassi,(unknown),Susumu Kobayashi,Annalisa Di Ruscio	16
9	Alternative splicing of APOBEC3D generates functional diversity and its role as a DNA mutator 2020 ·International Journal of Hematology ·Hisashi Takei,(unknown),(unknown),Hiroyuki Yamazaki,Tadahiko Matsumoto,Yasuhiro Kazuma,Masanori Fujii,Sohei Nakayama,Ikei S. Kobayashi,Keisuke Shindo,Riu Yamashita,Kotaro Shirakawa,Akifumi Takaori‐Kondo,Susumu Kobayashi	4
10	Preclinical Characterization of Mobocertinib Highlights the Putative Therapeutic Window of This Novel EGFR Inhibitor to EGFR Exon 20 Insertion Mutations 2020 ·JTO Clinical and Research Reports ·(unknown),Ikei S. Kobayashi,Susumu Kobayashi,Daniel B. Costa	17
11	EGFR-A763_Y764insFQEA Is a Unique Exon 20 Insertion Mutation That Displays Sensitivity to Approved and In-Development Lung Cancer EGFR Tyrosine Kinase Inhibitors 2020 ·JTO Clinical and Research Reports ·(unknown),(unknown),Hollis Viray,Andreas Varkaris,Masanori Fujii,Deepa Rangachari,Paul A. VanderLaan,Ikei S. Kobayashi,Susumu Kobayashi,Daniel B. Costa	53
12	Styryl quinazolinones and its ethynyl derivatives induce myeloid differentiation 2019 ·Bioorganic & Medicinal Chemistry Letters ·Sridhar Radhakrishnan,Riyaz Syed,Hisashi Takei,Ikei S. Kobayashi,(unknown),(unknown),Ähmed Kamal,Daniel G. Tenen,Susumu Kobayashi	0
13	Styryl Quinazolinones as Potential Inducers of Myeloid Differentiation via Upregulation of C/EBPα 2018 ·Molecules ·Sridhar Radhakrishnan,Hisashi Takei,Riyaz Syed,Ikei S. Kobayashi,(unknown),Ähmed Kamal,Daniel G. Tenen,Susumu Kobayashi	6
14	Roles of coagulation pathway and factor Xa in rat mesangioproliferative glomerulonephritis 2006 ·Laboratory Investigation ·Keiko Nomura,Ning Liu,Kojiro Nagai,(unknown),Ikei S. Kobayashi,Fumiaki Nogaki,Misa Tanaka,Hidenori Arai,Atsushi Fukatsu,Toru Kita,Takahiko Ono	25
15	Chromosomal mapping of hyperserum IgA and glomerular IgA deposition in a high IgA (HIGA) strain of DdY mice 2005 ·Kidney International ·Fumiaki Nogaki,(unknown),Tadashi Kamata,Ikei S. Kobayashi,Keiko Nomura,(unknown),(unknown),Takahiko Ono,Shigeki Miyawaki,Tadao Serikawa,Haruyoshi Yoshida,Toru Kita,Eri Muso	6
16	Quantitative trait loci (QTL) analysis reveals a close linkage between the hinge region and trimeric IgA dominancy in a high IgA strain (HIGA) of ddY mice 2004 ·European Journal of Immunology ·(unknown),Fumiaki Nogaki,Ikei S. Kobayashi,Tadashi Kamata,Takahiko Ono,Shigeki Miyawaki,Tadao Serikawa,Haruyoshi Yoshida,Toru Kita,Eri Muso	8
17	Role of transforming growth factor‐β/Smad signalling pathway in enhanced production of glomerular extracellular matrix in IgA nephropathy of high‐serum‐IgA ddY mice 2002 ·Nephrology ·Yutaka Kanamaru,Atsuhito Nakao,Chisei Ra,Ko Okumura,Eri Muso,Hideoki Ogawa,Ikei S. Kobayashi,Satoshi Horikoshi,(unknown)	4
18	Up-Regulated TGF-β mRNA Expression in Splenic T Cells of High IgA-Prone Mice: A Murine Model of IgA Nephropathy with Glomerulosclerosis 2001 ·The Nephron journals/Nephron journals ·Atsushi Oyama,Eri Muso,Takahiko Ono,Hiroyuki Matsushima,Masatomo Yashiro,(unknown),Tadashi Kamata,Fumiaki Nogaki,Ikei S. Kobayashi,Shigeki Miyawaki,Haruyoshi Yoshida,Shigetake Sasayama	4
19	Increased Frequency of Surface IgA-Positive Plasma Cells in the Intestinal Lamina Propria and Decreased IgA Excretion in Hyper IgA (HIGA) Mice, a Murine Model of IgA Nephropathy with Hyperserum IgA 2000 ·The Journal of Immunology ·Tadashi Kamata,Fumiaki Nogaki,Sidonia Fagarasan,Toshio Sakiyama,Ikei S. Kobayashi,Shigeki Miyawaki,Koichi Ikuta,Eri Muso,Haruyoshi Yoshida,Shigetake Sasayama,Tasuku Honjo	67
20	Interleukin 12 induces crescentic glomerular lesions in a high IgA strain of ddY mice, independently of changes in IgA deposition 2000 ·Nephrology Dialysis Transplantation ·Fumiaki Nogaki,Eri Muso,Ikei S. Kobayashi,Hitoshi Kusano,(unknown),Tadashi Kamata,Atsushi Oyama,Takahiko Ono,Shigeki Miyawaki,Haruyoshi Yoshida,Shigetake Sasayama	22

About Ikei S. Kobayashi

Ikei S. Kobayashi is a scholar working on Nephrology, Gastroenterology and Virology, having authored 24 papers that have together received 337 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (6 papers), Lung Cancer Treatments and Mutations (6 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Nephrology (54 citations), Oncology (109 citations) and Pulmonary and Respiratory Medicine (122 citations). Ikei S. Kobayashi has collaborated with scholars based in Japan, United States and Singapore. Frequent co-authors include Susumu Kobayashi, Daniel B. Costa, Fumiaki Nogaki, Shigeki Miyawaki, Tadashi Kamata, Eri Muso, Haruyoshi Yoshida, Masanori Fujii, Shigetake Sasayama and Hollis Viray. Their work appears in journals such as Blood, The Journal of Immunology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact